Loading stock data…
PACS
$35.20+0.13 (+0.37%)
After Hours$35.90+0.70 (+1.99%)· Last close Jun 9
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
PACS Group, Inc. in the Healthcare sector is trading at $35.20. Wall Street consensus targets $49.17 (6 analysts), implying a +39.7% move over the next 12 months. The stock is currently 18% below its 52-week high of $43.08, remaining 24.4% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +39.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$35.20
Potential Downside
0%
Whystock Fair Value$35.20
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, an...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
23.50%
Volume
Today's trading volume
561,349
Recent News
PACS Group's (NYSE:PACS) Performance Is Even Better Than Its Earnings Suggest
PACS Group, Inc.'s ( NYSE:PACS ) strong earnings report was rewarded with a positive stock price move. Our analysis...
PACS Group Q1 Earnings Call Highlights
PACS Group (NYSE:PACS) reported a strong start to 2026, with executives citing higher occupancy, improved skilled mix and continued progress integrating acquired facilities as drivers of first-quarter performance. On the company’s earnings call, Chairman and CEO Jason Murray said PACS entered the y
PACS Group (PACS) Is Up 22.1% After Q1 Beat, Guidance Hike and Buyback Launch
PACS Group, Inc. recently reported that first-quarter 2026 revenue rose to US$1,420.49 million with net income of US$80.7 million, while reaffirming full-year 2026 revenue guidance of US$5.65–US$5.75 billion and authorizing a US$250 million share repurchase program. Alongside acquiring Ridgeway Senior Living in Anchorage and planning a new 150-bed skilled nursing facility, the company lifted its 2026 adjusted EBITDA outlook as portfolio maturation, improved occupancy, and contract...
Assessing PACS Group (PACS) Valuation After Q1 Earnings Beat And New US$250 Million Buyback
PACS Group (PACS) is back in focus after reporting first quarter results that surpassed analyst expectations, lifting adjusted EBITDA guidance and unveiling a new $250 million share repurchase program, alongside reaffirmed 2026 revenue targets. See our latest analysis for PACS Group. The stock has reacted sharply to the Q1 beat, revised guidance and new buyback, with a 1 day share price return of 28.56% and a 1 year total shareholder return of well over 7x. This indicates strong momentum...
Why PACS Group Stock Surged Today
The post-acute care leader sees plenty of attractive acquisition targets.